DNV conducted an audit of ISO13485：2016 on Wuzhou Victory Biotech during 2021/04/06~04/08. Wuzhou Victory Biotech is well prepared for the manufacture of Hydrogel wound dressing and the Bone graft substitutes.
As part of the development strategy, the new facility in Foshan has been successfully completed. This facility will focus on the research, development, and manufacturing of Type I medical grade collagen.
Guangdong Victory Biotech Co., Ltd. successfully underwent and passed the periodic audit for ISO 13485:2016, as well as the manufacturing of bovine collagen in compliance with ISO 22442-1:2007, ISO 22442-2:2007, and ISO 22442-3:2007.
Guangdong Victory Biotech passed the DNV annual audit of ISO13485：2003 and the manufacture of bovine collagen as per the ISO22442-1:2007, ISO22442-2:2007, ISO22442-3:2007.
The 5th Collagen Industry Forum will be held during Nov. 30, 2017~Dec. 01, 2017 in Guangzhou. Shenguan Holding (Group), the parent company of Guangdong Victory Biotech, sponsors the annual event of the year.
